Skip to main content
Erschienen in:

17.05.2021 | Original Article

Early intervention of the perioperative multidisciplinary team approach decreases the adverse events during neoadjuvant chemotherapy for esophageal cancer patients

verfasst von: Yasuhiro Shirakawa, Kazuhiro Noma, Naoaki Maeda, Shunsuke Tanabe, Kazufumi Sakurama, Ayumi Sonoyama-Hanaoka, Aiko Yoshitomi, Reiko Kohno-Yamanaka, Yoshihiko Soga, Toshiyoshi Fujiwara

Erschienen in: Esophagus | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Multidisciplinary team (MDT) approach has become a standard for perioperative patient care, including in esophageal cancer. In our institution, the Perioperative Management Center (PERiO) has been doing an MDT approach for patients undergoing esophageal cancer surgery since 2009. On the other hand, neoadjuvant therapy has also been becoming standard for many malignancies, including esophageal cancer. In Japan, neoadjuvant chemotherapy (NAC) for esophageal cancer is standard now. However, there have been no reports about when is the best time to start the MDT approach for patients with neoadjuvant therapy. In this study, the best start time for the MDT approach for esophageal cancer patients with NAC was examined from the perspective of adverse events during chemotherapy and perioperative period.

Methods

All cases underwent thoracoscopic esophagectomy in the prone position (TEPP) after NAC. The PERiO Intervention group that started before NAC (n = 100) was compared with the PERiO Intervention group that started after NAC (n = 77). Eventually, 54 paired cases were matched by propensity score matching.

Results

The adverse event rate during chemotherapy, especially oral complications, was significantly decreased in the PERiO Intervention started before the NAC group (P = 0.007). Furthermore, weight loss during the period from chemotherapy to surgery was significantly reduced in the group that started before NAC (P = 0.033).

Conclusion

The MDT approach should be started before NAC in patients undergoing esophageal cancer surgery to prevent adverse events during chemotherapy and provide safe perioperative conditions.
Literatur
1.
Zurück zum Zitat Fearon KC, Ljungqvist O, Von Meyenfeldt M, et al. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr. 2005;24:466–77.CrossRef Fearon KC, Ljungqvist O, Von Meyenfeldt M, et al. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr. 2005;24:466–77.CrossRef
2.
Zurück zum Zitat Findlay JM, Gillies RS, Millo J, et al. Enhanced recovery for esophagectomy: a systematic review and evidence-based guidelines. Ann Surg. 2014;259:413–31.CrossRef Findlay JM, Gillies RS, Millo J, et al. Enhanced recovery for esophagectomy: a systematic review and evidence-based guidelines. Ann Surg. 2014;259:413–31.CrossRef
3.
Zurück zum Zitat Makiura D, Ono R, Inoue J, et al. Impact of sarcopenia on unplanned readmission and survival after esophagectomy in patients with esophageal cancer. Ann Surg Oncol. 2018;25:456–64.CrossRef Makiura D, Ono R, Inoue J, et al. Impact of sarcopenia on unplanned readmission and survival after esophagectomy in patients with esophageal cancer. Ann Surg Oncol. 2018;25:456–64.CrossRef
4.
Zurück zum Zitat Mizuno H, Mizutani S, Ekuni D, et al. New oral hygiene care regimen reduces postoperative oral bacteria count and number of days with elevated fever in ICU patients with esophageal cancer. J Oral Sci. 2018;60:536–43.CrossRef Mizuno H, Mizutani S, Ekuni D, et al. New oral hygiene care regimen reduces postoperative oral bacteria count and number of days with elevated fever in ICU patients with esophageal cancer. J Oral Sci. 2018;60:536–43.CrossRef
5.
Zurück zum Zitat Takahashi-Arimasa K, Kohno-Yamanaka R, Soga Y, et al. Efficacy of oral care provided by interprofessional collaboration for a patient with esophageal cancer associated with post-polio syndrome during neoadjuvant chemotherapy. Acta Med Okayama. 2019;73:71–6.PubMed Takahashi-Arimasa K, Kohno-Yamanaka R, Soga Y, et al. Efficacy of oral care provided by interprofessional collaboration for a patient with esophageal cancer associated with post-polio syndrome during neoadjuvant chemotherapy. Acta Med Okayama. 2019;73:71–6.PubMed
6.
Zurück zum Zitat Atkins BZ, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg. 2004;78:1170–6.CrossRef Atkins BZ, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg. 2004;78:1170–6.CrossRef
7.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.CrossRef Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.CrossRef
8.
Zurück zum Zitat Akiyama H, Tsurumaru M, Kawamura T, et al. Principles of surgical treatment for carcinoma of the esophagus analysis of lymph node involvement. Ann Surg. 1981;194:438–45.CrossRef Akiyama H, Tsurumaru M, Kawamura T, et al. Principles of surgical treatment for carcinoma of the esophagus analysis of lymph node involvement. Ann Surg. 1981;194:438–45.CrossRef
9.
Zurück zum Zitat Akiyama H, Tsurumaru M, Udagawa H, et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;220:364–73.CrossRef Akiyama H, Tsurumaru M, Udagawa H, et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;220:364–73.CrossRef
10.
Zurück zum Zitat Fujita H, Sueyoshi S, Tanaka T, et al. Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomy. World J Surg. 2003;27:571–9.CrossRef Fujita H, Sueyoshi S, Tanaka T, et al. Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomy. World J Surg. 2003;27:571–9.CrossRef
11.
Zurück zum Zitat Igaki H, Tachimori Y, Kato H. Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg. 2004;239:483–90.CrossRef Igaki H, Tachimori Y, Kato H. Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg. 2004;239:483–90.CrossRef
12.
Zurück zum Zitat Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg. 2014;260:259–66.CrossRef Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg. 2014;260:259–66.CrossRef
13.
Zurück zum Zitat Takeuchi H, Miyata H, Ozawa S, et al. Comparison of short-term outcomes between open and minimally invasive esophagectomy for esophageal cancer using a nationwide database in Japan. Ann Surg Oncol. 2017;24:1821–7.CrossRef Takeuchi H, Miyata H, Ozawa S, et al. Comparison of short-term outcomes between open and minimally invasive esophagectomy for esophageal cancer using a nationwide database in Japan. Ann Surg Oncol. 2017;24:1821–7.CrossRef
14.
Zurück zum Zitat Stephens MR, Lewis WG, Brewster AE, et al. Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer. Dis Esophagus. 2006;19:164–71.CrossRef Stephens MR, Lewis WG, Brewster AE, et al. Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer. Dis Esophagus. 2006;19:164–71.CrossRef
15.
Zurück zum Zitat Watanabe M, Okamura A, Toihata T, et al. Recent progress in perioperative management of patients undergoing esophagectomy for esophageal cancer. Esophagus. 2018;15:160–4.CrossRef Watanabe M, Okamura A, Toihata T, et al. Recent progress in perioperative management of patients undergoing esophagectomy for esophageal cancer. Esophagus. 2018;15:160–4.CrossRef
16.
Zurück zum Zitat Soga Y, Shirakawa Y, Fujiwara T, et al. recent changes and improvements in multidisciplinary perioperative management from a nutritional perspective: dental specialty should be considered important. Curr Oral Health Reports. 2019;6:70–4.CrossRef Soga Y, Shirakawa Y, Fujiwara T, et al. recent changes and improvements in multidisciplinary perioperative management from a nutritional perspective: dental specialty should be considered important. Curr Oral Health Reports. 2019;6:70–4.CrossRef
18.
Zurück zum Zitat Japanese Classification of Esophageal Cancer. 11th Edition: part I. Esophagus. 2017;14:1–36.CrossRef Japanese Classification of Esophageal Cancer. 11th Edition: part I. Esophagus. 2017;14:1–36.CrossRef
19.
Zurück zum Zitat Japanese Classification of Esophageal Cancer. 11th Edition: part II and III. Esophagus. 2017;14:37–65.CrossRef Japanese Classification of Esophageal Cancer. 11th Edition: part II and III. Esophagus. 2017;14:37–65.CrossRef
20.
Zurück zum Zitat Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors (UICC international union against cancer). 8th ed. Oxford: Wiley-Blackwell; 2017. Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors (UICC international union against cancer). 8th ed. Oxford: Wiley-Blackwell; 2017.
21.
Zurück zum Zitat Health UDo, Services H. Common Terminology Criteria for Adverse Events (CTCAE) v5. 0. Published Nov. 27, 2017. Health UDo, Services H. Common Terminology Criteria for Adverse Events (CTCAE) v5. 0. Published Nov. 27, 2017.
22.
Zurück zum Zitat WHO. Handbook for reporting results of cancer treatment. Geneva: WHO Health Organisation; 1979. WHO. Handbook for reporting results of cancer treatment. Geneva: WHO Health Organisation; 1979.
23.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRef Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRef
24.
Zurück zum Zitat Low DE, Allum W, De Manzoni G, et al. Guidelines for perioperative care in esophagectomy: enhanced recovery after surgery (ERAS(R)) society recommendations. World J Surg. 2019;43:299–330.CrossRef Low DE, Allum W, De Manzoni G, et al. Guidelines for perioperative care in esophagectomy: enhanced recovery after surgery (ERAS(R)) society recommendations. World J Surg. 2019;43:299–330.CrossRef
25.
Zurück zum Zitat Takagi K, Yoshida R, Yagi T, et al. Effect of an enhanced recovery after surgery protocol in patients undergoing pancreaticoduodenectomy: a randomized controlled trial. Clin Nutr. 2019;38:174–81.CrossRef Takagi K, Yoshida R, Yagi T, et al. Effect of an enhanced recovery after surgery protocol in patients undergoing pancreaticoduodenectomy: a randomized controlled trial. Clin Nutr. 2019;38:174–81.CrossRef
Metadaten
Titel
Early intervention of the perioperative multidisciplinary team approach decreases the adverse events during neoadjuvant chemotherapy for esophageal cancer patients
verfasst von
Yasuhiro Shirakawa
Kazuhiro Noma
Naoaki Maeda
Shunsuke Tanabe
Kazufumi Sakurama
Ayumi Sonoyama-Hanaoka
Aiko Yoshitomi
Reiko Kohno-Yamanaka
Yoshihiko Soga
Toshiyoshi Fujiwara
Publikationsdatum
17.05.2021
Verlag
Springer Singapore
Erschienen in
Esophagus / Ausgabe 4/2021
Print ISSN: 1612-9059
Elektronische ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-021-00844-y

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Metastasiertes CRC: besser Checkpointhemmer im Doppelpack!

Die Kombination von Nivolumab plus Ipilimumab ist beim metastasierten Kolorektalkarzinom mit MSI-H- oder dMMR klar im Vorteil gegenüber einer Nivolumab-Monotherapie: Das Progressionsrisiko war damit in einer Phase-3-Studie um 38% reduziert.

Riesenzellarteriitis: bilaterale Biopsie der Temporalarterien von Vorteil

Die Riesenzellarteriitis (RZA) erfordert eine rasche und präzise Diagnose, da innerhalb weniger Tage ein schwerer, irreversibler Sehverlust drohen kann. In diesem Zusammenhang scheint die bilaterale Biopsie der Temporalarterien (TAB) der unilateralen überlegen zu sein.

Große Trinkmengen bei Blasentumoren möglicherweise von Nachteil

Beim nicht-muskelinvasiven Blasenkrebs scheint eine hohe Flüssigkeitszufuhr keinen schützenden Effekt in Bezug auf das Risiko eines Rezidivs oder einer Krankheitsprogression zu haben. Eine niederländische Studie legt sogar nahe, dass große Trinkmengen das Fortschreiten der Erkrankung begünstigen könnten.

Höhere Trefferquoten bei Brustkrebsscreening dank KI?

Künstliche Intelligenz unterstützt bei der Auswertung von Mammografie-Screenings und senkt somit den Arbeitsaufwand für Radiologen. Wie wirken sich diese Technologien auf die Trefferquote und die Falsch-positiv-Rate aus? Das hat jetzt eine Studie aus Schweden untersucht.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.